2021

Apr 13, 2021View PDF

Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China’s NMPA

Antengene Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index

Antengene Included in the Shenzhen-Hong Kong Stock Connect

Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin’s Lymphoma